ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Pádua, R. A. F.
Right arrow Articles by Cardoso, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Pádua, R. A. F.
Right arrow Articles by Cardoso, R. F.
Annals of Clinical & Laboratory Science 39:405-408 (2009)
© 2009 Association of Clinical Scientists


Case Report

Haemophilus influenzae Serotype a Meningitis

Rubia Andreia Falleiros de Pádua1, Regiane Bertin de Lima Scodro1, Luciana Dias Ghiraldi2, Vera Lúcia Dias Siqueira1, Yandara Keiko Yamashita3, César Helbel4 and Rosilene Fressatti Cardoso1
1 Department of Clinical Analyses, 2 Health Sciences student, 3 Medical student, all at the State University of Maringá, Paraná, Brazil; 4 Infectologist, State University Hospital of Maringá, Paraná, Brazil

Address correspondence to Rosilene Fressatti Cardoso, Departamento de Análises Clínicas, Universidade Estadual de Maringá, Avenida Colombo, 5790, CEP: 87020-900, Bloco J-90, sala 05, Maringá, Paraná, Brasil; tel 55 44 3261 4797; fax 55 44 3261 4797; e-mail rfcardoso{at}uem.br.


    Abstract
 Top
 Abstract
 Introduction
 Case Report
 Discussion
 References
 
This work describes a case of Haemophilus influenzae serotype a meningitis in Brazil, after almost a decade since the introduction of Haemophilus influenzae serotype b conjugate vaccine. Uncertainty about the replacement of H. influenzae serotypes as a cause of invasive diseases justifies continuous surveillance, coupled with investigations of carriage rates and requirements of chemoprophylaxis in contact persons.

Keywords: Haemophilus influenzae serotype b, Haemophilus influenzae serotype a, meningitis


    Introduction
 Top
 Abstract
 Introduction
 Case Report
 Discussion
 References
 
Haemophilus influenzae (Hi) is a Gram-negative pleomorphic bacillus that may present a polysaccharide capsule. Encapsulated strains may be differentiated into 6 serotypes (a to f) [1], of which H. influenzae serotype b (Hib) is the main cause of invasive diseases [2]. It is estimated that the bacillus causes >3 million cases of serious disease, mainly meningitis and pneumonia in children <5-yr-old, with approximately 386,000 deaths each year worldwide [2].

Invasive Hi diseases in children were almost exclusively caused by serotype b prior to the introduction of H. influenzae serotype b conjugate vaccine in several countries in 1988 and in 1999 in Brazil [3]. According to de Almeida et al [3], epidemiological data show that during the prevaccination period (from 1990 to 1999) in Brazil, the annual mean coefficients of incidence were 22.3 and 8.8/100,000 in children age <1 yr and from 1 to 4 yr, respectively. After the implementation of Hib vaccine in the regular immunization program, the incidence of Hib meningitis in Brazil was reduced significantly [4]. Although the vaccine brought great benefits due to the decrease in Hib meningitis, it was suspected that other serotypes and non-typable strains (non-encapsulated) probably became more frequent in infectious processes [5,6].

This report describes a case of meningitis caused by Haemophilus influenzae serotype a (Hia) in southern Brazil, almost a decade after the introduction of Haemophilus influenzae serotype b conjugate vaccine.


    Case Report
 Top
 Abstract
 Introduction
 Case Report
 Discussion
 References
 
A 5-mo-old white girl, from Maringá, Paraná, Brazil, was hospitalized at the University Hospital of the State University of Maringá in June 2007. The child had been greatly irritable, crying excessively for 3 days, and running a fever of 39°C; one jet-like vomit was reported by her parents.

Laboratory data revealed cloudy cerebrospinal fluid (CSF) with 8,523 leukocytes/mm3, predominantly polymorphonuclear (95%), non-detectable glucose, and total protein 272 mg/dl. A Gram stain of CSF sediment revealed an abundance of Gram-negative bacilli. Bacterial antigen screening for group B streptococci, H. influenzae serotype b, Streptococcus pneumoniae, Neisseria meningitidis A, B, C, Y, W135, and Escherichia coli K1 was negative by agglutination tests (Pastorex meningitis test, Bio-Rad, Marnes-la-Coquette, France). CSF cultured on chocolate agar and incubated at 35°C for 24 hr in 5% CO2 showed Gram-negative bacilli growth that was identified as Hia by biochemical and serologic tests. An antimicrobial susceptibility test carried out by disk diffusion showed susceptibility to ampicillin, chloramphenicol, ceftriaxone, and trimethoprim-sulfametoxazole. A β-lactamase test performed with a Cefinase disc test (BD BBL, Sparks, MD, USA) yielded a negative result [7].

The patient was treated with iv ceftriaxone (350 mg tid) and iv dexamethazone (0.25 mg qid). Sodium dipyrone was administered when fever was present. The patient was isolated for 24 hr after the start of treatment. Three days later, the child experienced another jet-like vomit. From this time until the 64th day of hospitalization, 7 CSF collections were undertaken for cytological, biochemical, and microbiological tests, which revealed leukocytes and biochemical alterations (Table 1Go). On the 17th day of hospitalization, the patient had a tonic-clonic convulsion. Aspiration of the upper respiratory tract was carried out; an initial dose of iv phenobarbital (70 mg) was administered, with a 35 mg qd maintenance dose.


View this table:
[in this window]
[in a new window]

 
Table 1. Results of biochemical assays and microscopy of CSF in a patient with Haemophilus influenzae serotype a meningitis during hospitalization at the University Hospital of the State University of Maringá, Paraná, Brazil.
 
Although the Gram stain was negative by the 4th day, CSF cytological changes continued to be observed on the 29th day of hospitalization; chloramphenicol (175 mg qid) was added and maintained for 14 days. Owing to cytological alterations in CSF, ceftriaxone was replaced by ceftazidime (450 mg tid) plus gentamicin (56 mg qd) on the 45th day of hospitalization and maintained for 12 days.

Four skull tomographs and nuclear magnetic resonance (NMR) images were undertaken. Although the tomographs did not show any malformations, anatomical variations, and collections or abscesses, the NMRs revealed frontal and parietal saliencies consistent with an inflammatory process. Other tests, such as serology for Histoplasma capsulatum, Herpes simplex 1 and 2, HTLV 1 and 2, and PCR for tuberculosis in CSF, were carried out, showing negative results. Although determinations of total-CH50 complement and immunoglobulins (IgA, IgG, IgM, and IgE) were undertaken, only IgA and IgG showed slightly low levels.

After hospitalization for 65 days (including 57 days with and 8 without antibiotics) and recovery of good health, the patient was discharged from the Neurology Department without anticonvulsive drug therapy. Clinical follow-up has revealed good psychomotor development.


    Discussion
 Top
 Abstract
 Introduction
 Case Report
 Discussion
 References
 
In the current case of Hia meningitis, no underlying illness or immunological deficiency was detected that would have predisposed the patient to such prolonged illness as described. Although a few reports have already been described in Brazil [8,9], ours is the first Hia invasive disease case in Maringá, Paraná, Brazil. The importance of the current case report is self-evident, especially in Brazil, where Hib vaccine coverage is high. Broad-coverage immunization with the tetravalent vaccine against diphtheria, tetanus, whooping cough, and Hib has reduced the incidence of Hib-caused invasive illnesses and the rate of nasopharyngeal colonization [8,10,11].

Our patient had not received the third dose of tetravalent vaccine, normally given in the sixth month. Ribeiro et al [8] reported Hia-caused meningitis in infants who had only received 2 or 3 doses of the tetravalent vaccine. Tetravalent vaccine fails to protect against infections caused by Hi serotypes other than b. Further studies are needed to see if that is coincidence. It would be interesting to monitor a possible trend of normal flora replacement and the appearance of other agents that could cause invasive diseases [12].

Some authors [8,1317] have reported an increase in non-b H. influenzae nasopharyngeal colonization and invasive diseases since the introduction of Hib conjugate vaccine. In a recent study in northeastern Brazil, Ribeiro et al [9] reported that Hia-caused meningitis was a local and transitory phenomenon that occurred during the first years after Hib conjugate vaccine introduction (from 0.01 to 0.14 cases per 100,000 population), but it was not observed in the following years, without any threat worldwide. In analyses of population-based studies and the relevant literature, WHO [2], Millar et al [18] and Ladhani et al [19] failed to find evidence of increased incidences of non-b H. influenzae-caused invasive diseases.

According to Bruce et al [20], there are several possible explanations for the high proportion of Hia diseases after the vaccine introduction. The authors suggest (a) an increase in Hia virulence, (b) a reduction in Hib colonization, which may lead to an opened ecologic niche for the colonization by other microorganisms, and finally, (c) that the reduction of Hib diseases may be highlighting the Hia cases. This last factor probably could explain the case reported here, considering that in our region, no Hia meningitis was previously reported after Hib vaccine implementation.

Lipsitch [21], based on a mathematical model, suggested that the extent and importance of serotype replacement (if it occurs) depend on such factors as vaccine coverage, differences in the colonization biology, and interactions among the bacterial types.

Although there is concern that Hia and other serotypes of Hi may be emerging as agents of meningitis and other invasive diseases, this possibility must be carefully evaluated to elucidate the risks of passing disease by carriage of these microorganisms [5]. Continuous monitoring for invasive diseases is mandatory, coupled with investigations of the number of carriers and of the need of chemoprophylaxis in contact persons [20].

The current authors emphasize the urgent need for more information about Hi serotypes. Clinical microbiology laboratories should identify Hi serotype profiles in order to clarify their clinical importance. The authors also stress the need for reevaluation of current immunization schedules and possible modifications of the Hib conjugate vaccine in order to protect against invasive disease caused by other Hi strains.


    References
 Top
 Abstract
 Introduction
 Case Report
 Discussion
 References
 

  1. Pittman M. Variation and type specificity in the bacterial species Haemophilus influenzae. J Exp Med 1931;53:471–492.[Abstract]
  2. World Health Organization. WHO position paper on Haemophilus influenzae type b conjugate vaccines. Wkly Epidemiol Rec 2006;81:445–452.[Medline]
  3. de Almeida AECC, Filippis I, Abreu AO, Ferreira DG, Gemal AL, Marzochi KBF. Occurrence of Haemophilus influenzae strains in three Brazilian states since the introduction of a conjugate Haemophilus influenzae type b vaccine. Braz J Med Biol Res 2005;38:777–781.[Medline]
  4. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polyssacharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev 2000;13:302–317.[Abstract/Free Full Text]
  5. Hammitt LL, Block S, Hennessy TW, Debyle C, Peters H, Parkinson A, Singleton R, Butler JC. Outbreak of invasive Haemophilus influenzae serotype a disease. Pediatr Infect Dis J 2005;24:453–456.[Medline]
  6. Taube JM, Hutchins GM, Carrol KC, Vricella LA, Scheel J, Halushka MK. Haemophilus influenzae serotype f purulent pericarditis: a cause of death in a child with Down syndrome. Diagn Microbiol Infect Dis 2006; 56:87–89.[Medline]
  7. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Informational Supplement. CLSI Document M100-S-17, 2007; pp 56–58.
  8. Ribeiro GS, Reis JN, Cordeiro SM, Lima JBT, Gouveia EL, Petersen M, Salgado K, Silva HR, Zanella RC Almeida SCG, Brandileone MC, Reis MG, Ko AI. Prevention of Haemophilus influenzae type b (Hib) meningitis and emergence of serotype replacement with type a strains after introduction of Hib immunization in Brazil. J Infect Dis 2003;187:109–116.[Abstract/Free Full Text]
  9. Ribeiro GS, Lima JB, Reis JN, Gouveia EL, Cordeiro SM, Lobo TS, Pinheiro RM, Ribeiro CT, Neves AB, Salgado K, Silva HR, Reis MG, Ko AI. Haemophilus influenzae meningitis 5 years after introduction of the Haemophilus influenzae type b conjugate vaccine in Brazil. Vaccine 2007;25:4420–4428.[Medline]
  10. Takala AK, Eskola J, Leinonen M, Kayhty H, Nissinen A, Pekkanen E, Makela PH. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with a Hib conjugate vaccine. J Infect Dis 1991;164:982–986.[Abstract/Free Full Text]
  11. Wang SR, Lo WT, Chou CY, Chen YY, Tsai SY, Chu ML, Wang CC. Low rate of nasopharyngeal carriage and high rate of ampicillin resistance for Haemophilus influenzae among healthy children younger than 5 years old in northern Taiwan. J Microbiol Immunol Infect 2008;41:32–40.[Medline]
  12. Jin Z, Romero-Steiner S, Carlone GM, Robbins JB, Sheneerson R. Haemophilus influenzae type a infection and its prevention. Infection and Immunity 2007; 75:2650–2654.[Free Full Text]
  13. Perdue DG, Bulkow LR, Gellin BG, Davidson M, Petersen KM, Singleton RJ, Parkinson AJ. Invasive Haemophilus influenzae disease in Alaskan residents aged 10 years and older before and after infant vaccination programs. JAMA 2000;283:3089–3094.[Abstract/Free Full Text]
  14. Fickweiler K, Borte M, Fasshauer M, Spencker F-B, Handrick W, Rodloff A. Meningitis due to Haemophilus influenzae type f in an 8-year-old girl with congenital humoral immunodeficiency. Infection 2004;32:112–115.[Medline]
  15. Silva MENB, Silva P, Medeiros MIC, Neme SN, Macedo C, Marin JM. Nasopharyngeal colonization by Haemophilus influenzae in children attending day-care centers in Ribeirão Preto, State of São Paulo, Brazil. Braz J Microbiol 2006;37:33–38.
  16. Tsang RS, Mubareka S, Sill ML, Wylie J, Skinner S, Law DK. Invasive Haemophilus influenzae in Manitoba, Canada, in the postvaccination era. J Clin Microbiol 2006;44:1530–1535.[Abstract/Free Full Text]
  17. Dworkin MS, Park L, Borchardt SM. The changing epidemiology of invasive Haemophilus influenzae disease, especially in persons > or = 65 years old. Clin Infect Dis 2007;44:810–816.[Abstract/Free Full Text]
  18. Millar EV, O’Brien KL, Watt JP, Lingappa J, Pallipamu R, Rosenstein N, Hu D, Reid R, Santosham M. Epidemiology of invasive Haemophilus influenzae type a disease among Navajo and White Mountain Apache children, 1988–2003. Clin Infect Dis 2005;40:823–830.[Abstract/Free Full Text]
  19. Ladhani S, Ramsay M, Chandra M, Slack M. No evidence for Haemophilus influenzae serotype replacement in Europe after introduction of the Hib conjugate vaccine. Lancet Infect Dis 2008;8:275–276.[Medline]
  20. Bruce MG, Deeks SL, Zulz T, Navarro C, Palacios C, Case C, Hemsley C, Hennessy T, Corriveau A, Larke B, Sobel I, Lovgren M, Debyle C, Tsang R, Parkinson AJ. Epidemiology of Haemophilus influenzae serotype a, North American Arctic, 2000–2005. Emerg Infect Dis 2008;14:48–55.[Medline]
  21. Lipsitch M. Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae. Emerg Infect Dis 1999;5:336–345.[Medline]



This article has been cited by other articles:


Home page
J Med MicrobiolHome page
L. Kelly, R. S. W. Tsang, A. Morgan, F. B. Jamieson, and M. Ulanova
Invasive disease caused by Haemophilus influenzae type a in Northern Ontario First Nations communities
J. Med. Microbiol., March 1, 2011; 60(3): 384 - 390.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Pádua, R. A. F.
Right arrow Articles by Cardoso, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Pádua, R. A. F.
Right arrow Articles by Cardoso, R. F.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS